The Experts below are selected from a list of 309 Experts worldwide ranked by ideXlab platform
Cristine D. Delnevo - One of the best experts on this subject based on the ideXlab platform.
-
factors associated with e cigarette use a national Population Survey of current and former smokers
American Journal of Preventive Medicine, 2014Co-Authors: Daniel P. Giovenco, Jane M Lewis, Cristine D. DelnevoAbstract:Background Few national Surveys document the prevalence of e-cigarette use in the U.S. The existing metric to assess current use likely identifies individuals who have recently tried an e-cigarette but do not continue to use the product. Purpose To document the prevalence of e-cigarette ever use, current use, and established use in a nationally representative Survey of current and former cigarette smokers in the U.S. Methods A random sample of current and former cigarette smokers completed a web-based Survey in June 2013 ( n =2,136). Data were analyzed in November 2013. Multivariate logistic regression identified demographic and smoking-related factors associated with each use category. Point estimates with 95% CIs described e-cigarette use behaviors (e.g., preferred brand, purchasing patterns) for each group. Results Almost half of respondents had tried e-cigarettes (46.8%), but prevalence of established use remained low (3.8%). Although trial of e-cigarettes was highest among daily smokers, the odds of being an established e-cigarette user were greater for former smokers (OR=3.24, 95% CI=1.13, 9.30, p Conclusions Improved Survey measures for e-cigarette use are needed. The identification of established e-cigarette users may provide insight to product features or other individual factors that are associated with sustained use of e-cigarettes.
-
Factors associated with e-cigarette use: A national Population Survey of current and former smokers
American Journal of Preventive Medicine, 2014Co-Authors: Daniel P. Giovenco, M. Jane Lewis, Cristine D. DelnevoAbstract:Background: Few national Surveys document the prevalence of e-cigarette use in the U.S. The existing metric to assess current use likely identifies individuals who have recently tried an e-cigarette but do not continue to use the product. Purpose: To document the prevalence of e-cigarette ever use, current use, and established use in a nationally representative Survey of current and former cigarette smokers in the U.S. Methods: A random sample of current and former cigarette smokers completed a web-based Survey in June 2013 (n=2,136). Data were analyzed in November 2013. Multivariate logistic regression identified demographic and smoking-related factors associated with each use category. Point estimates with 95% CIs described e-cigarette use behaviors (e.g., preferred brand, purchasing patterns) for each group. Results: Almost half of respondents had tried e-cigarettes (46.8%), but prevalence of established use remained low (3.8%). Although trial of e-cigarettes was highest among daily smokers, the odds of being an established e-cigarette user were greater for former smokers (OR=3.24, 95% CI=1.13, 9.30, p
Junichi Shimizu - One of the best experts on this subject based on the ideXlab platform.
-
Development of a short version of the sense of coherence scale for Population Survey
Journal of Epidemiology and Community Health, 2007Co-Authors: Taisuke Togari, Yoshihiko Yamazaki, Kazuhiro Nakayama, Junichi ShimizuAbstract:A three-item sense of coherence (SOC) scale was developed, incorporating the definitions of the three subordinate concepts of SOC for use in Population Surveys. A cross-sectional internet Survey was conducted in the latter part of July 2006. Cronbach's alpha was 0.84. The correlation coefficient of SOC-13 and the newly devised University of Tokyo Health Sociology version of the SOC Scale (SOC-3-UTHS) was 0.51. As regards correlation with a health index, SOC-3-UTHS had a significant association, although this association was somewhat weaker than that of SOC-13. Therefore, certain levels of convergent and concurrent validities of SOC-3-UTHS have been indicated.
Jouko Lonnqvist - One of the best experts on this subject based on the ideXlab platform.
-
Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general Population Survey
European Archives of Psychiatry and Clinical Neuroscience, 2008Co-Authors: Jaana Suvisaari, Samuli I Saarni, Sami Pirkola, Seppo Koskinen, Jouko Lonnqvist, Jonna Perälä, Tommi Härkänen, Matti Joukamaa, Antti ReunanenAbstract:Schizophrenia and other psychotic disorders are associated with increased risk of developing type 2 diabetes. However, previous studies are mainly based on clinical samples where the comorbidity may be stronger. We investigated in a general Population Survey the prevalence of type 2 diabetes in persons with psychotic disorders and in users of antipsychotic medication. The study was based on a nationally representative two-stage cluster sample of 8,028 persons aged 30 or over from Finland. Diagnostic assessment of psychotic disorders combined SCID-I interview and case note data. Prevalences of type 2 diabetes, adjusting for age and sex, were estimated by calculating predicted marginals. The prevalence estimate of type 2 diabetes was 22.0% among subjects with schizophrenia, 13.4% among subjects with other nonaffective psychosis and 6.1% in subjects without psychotic disorders. Only two subjects (3.4%) with affective psychosis had type 2 diabetes. Users of all types of antipsychotic medication had increased prevalence of type 2 diabetes. Our results suggest that type 2 diabetes is a major health concern among persons with schizophrenia and other nonaffective psychotic disorders and also in users of antipsychotic medication, but persons with affective psychosis in the general Population may not have increased prevalence of type 2 diabetes.
-
impact of psychiatric disorders on health related quality of life general Population Survey
British Journal of Psychiatry, 2007Co-Authors: Samuli I Saarni, Jaana Suvisaari, Harri Sintonen, Sami Pirkola, Seppo Koskinen, Arpo Aromaa, Jouko LonnqvistAbstract:Background Measurement of health-related quality of life (HRQoL) with generic preference-based instruments enables comparisons of severity across different conditions and treatments. This is necessary for rational public health policy. Aims To measure HRQoL decrement and loss of quality-adjusted life-years (QALYs) associated with pure and comorbid forms of depressive and anxiety disorders and alcohol dependence. Method A general Population Survey was conducted of Finns aged 30 years and over. Psychiatric disorders were diagnosed with the Composite International Diagnostic Interview and HRQoL was measured with the 15D and EQ–5D questionnaires. Results Dysthymia, generalised anxiety disorder and social phobia were associated with the largest loss of HRQoL on the individual level before and after adjusting for somatic and psychiatric comorbidity. On the Population level, depressive disorders accounted for 55%, anxiety disorders 30%, and alcohol dependence for 15% of QALY loss identified in this study. Conclusions Chronic anxiety disorders and dysthymia are associated with poorer HRQoL than previously thought.
David A. Macpherson - One of the best experts on this subject based on the ideXlab platform.
-
union membership and coverage database from the current Population Survey note
Industrial and Labor Relations Review, 2003Co-Authors: Barry T Hirsch, David A. MacphersonAbstract:This note describes the construction and provision of an Internet database providing private and public sector union membership, coverage, and density estimates compiled from the Current Population Survey (CPS). Economy-wide estimates are provided beginning in 1973, estimates by state, detailed industry, and detailed occupation begin in 1983, and estimates by metropolitan area begin in 1986. The database will be updated annually and can be accessed at http://www.unionstats.com/.
-
Employer-provided retiree health insurance: Who is covered?
Economics Letters, 1992Co-Authors: David A. MacphersonAbstract:Using August 1988 Current Population Survey data, this study finds employer-provided retiree health insurance coverage is higher among workers who are covered by a union contract, in industries with large firms, in the public sector, male; highly paid, and full-time. © 1992.
Samuli I Saarni - One of the best experts on this subject based on the ideXlab platform.
-
Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general Population Survey
European Archives of Psychiatry and Clinical Neuroscience, 2008Co-Authors: Jaana Suvisaari, Samuli I Saarni, Sami Pirkola, Seppo Koskinen, Jouko Lonnqvist, Jonna Perälä, Tommi Härkänen, Matti Joukamaa, Antti ReunanenAbstract:Schizophrenia and other psychotic disorders are associated with increased risk of developing type 2 diabetes. However, previous studies are mainly based on clinical samples where the comorbidity may be stronger. We investigated in a general Population Survey the prevalence of type 2 diabetes in persons with psychotic disorders and in users of antipsychotic medication. The study was based on a nationally representative two-stage cluster sample of 8,028 persons aged 30 or over from Finland. Diagnostic assessment of psychotic disorders combined SCID-I interview and case note data. Prevalences of type 2 diabetes, adjusting for age and sex, were estimated by calculating predicted marginals. The prevalence estimate of type 2 diabetes was 22.0% among subjects with schizophrenia, 13.4% among subjects with other nonaffective psychosis and 6.1% in subjects without psychotic disorders. Only two subjects (3.4%) with affective psychosis had type 2 diabetes. Users of all types of antipsychotic medication had increased prevalence of type 2 diabetes. Our results suggest that type 2 diabetes is a major health concern among persons with schizophrenia and other nonaffective psychotic disorders and also in users of antipsychotic medication, but persons with affective psychosis in the general Population may not have increased prevalence of type 2 diabetes.
-
impact of psychiatric disorders on health related quality of life general Population Survey
British Journal of Psychiatry, 2007Co-Authors: Samuli I Saarni, Jaana Suvisaari, Harri Sintonen, Sami Pirkola, Seppo Koskinen, Arpo Aromaa, Jouko LonnqvistAbstract:Background Measurement of health-related quality of life (HRQoL) with generic preference-based instruments enables comparisons of severity across different conditions and treatments. This is necessary for rational public health policy. Aims To measure HRQoL decrement and loss of quality-adjusted life-years (QALYs) associated with pure and comorbid forms of depressive and anxiety disorders and alcohol dependence. Method A general Population Survey was conducted of Finns aged 30 years and over. Psychiatric disorders were diagnosed with the Composite International Diagnostic Interview and HRQoL was measured with the 15D and EQ–5D questionnaires. Results Dysthymia, generalised anxiety disorder and social phobia were associated with the largest loss of HRQoL on the individual level before and after adjusting for somatic and psychiatric comorbidity. On the Population level, depressive disorders accounted for 55%, anxiety disorders 30%, and alcohol dependence for 15% of QALY loss identified in this study. Conclusions Chronic anxiety disorders and dysthymia are associated with poorer HRQoL than previously thought.